XML 55 R44.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Commitments and Contingencies - Additional Information (Detail) - USD ($) |  | 1 Months Ended | 3 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | ---
Jun. 15, 2022 | Aug. 31, 2022 | Jun. 30, 2022 | Sep. 30, 2022 | Mar. 31, 2022 | Sep. 16, 2021 | Jul. 31, 2021
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Percentage of common stock filed a lawsuit | 5.00% |  |  |  |  |  |
Legal and Other Expenses |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Litigation amount |  | $ 400,000 |  |  |  |  |
A G C Biologics Inc | Service Agreements |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Remaining obligations |  |  |  | $ 0 |  |  |
A G C Biologics Inc | Marzeptacog Alfa Activated And Dalcinonacog Alfa | Service Agreements |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Cost of Manufacturing Services |  |  |  |  | $ 700,000 |  |
Dalcinonacog Alfa | Service Agreements |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Remaining obligations |  |  |  | $ 0 |  |  |
Clinical trial services cost incurred on agreement termination |  |  | $ 800,000 |  |  |  |
Dalcinonacog Alfa | Service Agreements | Maximum |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Cost of services as per agreement |  |  |  |  |  |  | $ 6,500,000
Catalent Indiana, LLC. | Dalcinonacog alfa. |  |  |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |  |  |
Firm work order supporting clinical trials |  |  |  |  |  | $ 300,000 |

X
- Definition Clinical trial services cost incurred on agreement termination. + References No definition available. + Details
Name: | cbio_ClinicalTrialServicesCostIncurredOnAgreementTermination
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Commitments and contingencies disclosure. + References No definition available. + Details
Name: | cbio_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix: | cbio_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cost of manufacturing services related company. + References No definition available. + Details
Name: | cbio_CostOfManufacturingServices
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cost of services as per agreement. + References No definition available. + Details
Name: | cbio_CostOfServicesAsPerAgreement
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Firm work order supporting clinical trials. + References No definition available. + Details
Name: | cbio_FirmWorkOrderSupportingClinicalTrials
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation amount . + References No definition available. + Details
Name: | cbio_LitigationAmount
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of common stock filed a lawsuit. + References No definition available. + Details
Name: | cbio_PercentageOfCommonStockFiledLawsuit
Namespace Prefix: | cbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=cbio_LegalAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_AGCBiologicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cbio_MarzeptacogAlfaActivatedAndDalcinonacogAlfaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_DalcinonacogAlfaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_IntegrityBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cbio_GMPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |